Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06460324
Status:
COMPLETED
Last Update Posted:
2024-06-14
First Post:
2024-06-11
Brief Title:
A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2024-06-11
First Submit QC Date:
June 12 2024
Study First Post Date:
2024-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-12
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL